Flu and pneumonia vaccines for COPD patients
Part of Infections, Lungs & breathing clinical trials.
This study looks at whether getting both the flu shot and a pneumonia vaccine helps people with COPD stay healthier and reduce healthcare costs. If you have COPD and are between 45 and 80, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a COPD diagnosis confirmed by a lung function test (post-bronchodilator FEV1/FVC < 70%).
- You must be between 45 and 80 years old.
- You must be willing to sign a consent form.
- You cannot have other structural lung diseases (like bronchiectasis, interstitial lung disease, or prior TB).
- You cannot have lung cancer.
- You must not have had a pneumococcal vaccine (Pneumovax 23) in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood markers (special proteins) in patients who have had both a heart attack and pneumonia, to see how vaccination affects recovery. The goal is to understand whether flu and pneumonia vaccines are safe and helpful for people recovering from these two serious conditions together.
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
This trial is testing a new way to choose antibiotics for people with COPD who get pneumonia and need intensive care. The goal is to find the best treatment using a personalized approach.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
This study tests whether getting an RSV vaccine (a shot that protects against a common respiratory virus) can reduce the number of COPD flare-ups in people who have frequent episodes. If you qualify, you may receive the vaccine and be followed for a year to see if it helps keep you out of the hospital.
This trial tests whether giving a special antibiotic treatment to clear a common lung fungus (Pneumocystis jirovecii) can reduce how often COPD flare-ups happen. If you qualify, this might help you have fewer severe episodes.
Hear when a new Influenza and Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.